An investigational assay developed in the lab of David Alland, chief of infectious diseases and associate dean of clinical research at Rutgers New Jersey Medical School, could be used as a rapid point-of-care test to detect drug-resistant tuberculosis infections. Read the story on Healio.com.
Recent Posts
Archives
- April 2021 (2)
- March 2021 (4)
- February 2021 (4)
- January 2021 (5)
- December 2020 (4)
- November 2020 (3)
- October 2020 (3)
- September 2020 (4)
- August 2020 (1)
- July 2020 (5)
- June 2020 (4)
- May 2020 (5)
- April 2020 (4)
- February 2020 (2)
- January 2020 (4)
- December 2019 (8)
- November 2019 (6)
- October 2019 (6)
- September 2019 (3)
- August 2019 (3)
- July 2019 (4)
- June 2019 (3)
- May 2019 (4)
- April 2019 (3)
- March 2019 (6)
- February 2019 (5)
- January 2019 (2)
- December 2018 (2)
- November 2018 (6)
- October 2018 (3)
- September 2018 (4)
- July 2018 (5)
- June 2018 (5)
- May 2018 (1)
- April 2018 (1)
- March 2018 (2)
- February 2018 (3)
- January 2018 (2)
- December 2017 (2)
- November 2017 (1)
- October 2017 (1)
- September 2017 (2)
- August 2017 (2)
- July 2017 (1)
- May 2017 (1)
Categories
- News (151)
- Opportunity (1)
Tags
Africa
Botswana
cancer
capacity building
climate change
coronavirus
COVID-19
disasters
education
engineering
environment
epidemics
events
faculty
food
food security
fundraising
health equity
HIV/AIDS
infectious diseases
interview
Kenya
mental health
New Jersey
newsletter
nutrition
pandemic
partnership
partnerships
project map
research
Rutgers Giving Day
science denialism
seed grants
service
South Africa
student council
student council COVID-19 projects
students
Tanzania
telementoring
training
tuberculosis
vaccines
women's health